| Literature DB >> 27854082 |
F Abat1, J L Sánchez-Sánchez2, A M Martín-Nogueras2, J I Calvo-Arenillas2, J Yajeya3, R Méndez-Sánchez2, J C Monllau4,5, P E Gelber4,6.
Abstract
BACKGROUND: Patellar tendinopathy has a high prevalence rate among athletes. Different therapeutic options can be found in the current literature, but none of them has been clearly established as the gold standard. The purpose of this study is to compare, in a randomized controlled trial, the clinical efficacy of eccentric exercise combined with either an ultrasound-guided galvanic electrolysis technique (USGET) or conventional electrophysiotherapy to treat patellar tendinopathy.Entities:
Keywords: Electrolysis; Electrophysiotherapy; Galvanic; Patellar; Tendinopathy; Treatment; USGET
Year: 2016 PMID: 27854082 PMCID: PMC5112225 DOI: 10.1186/s40634-016-0070-4
Source DB: PubMed Journal: J Exp Orthop ISSN: 2197-1153
Demographic and clinical data of participants separated by treatment group
| Group 1 (Electro-physiotherapy) | Group 2 (USGET) |
| |
|---|---|---|---|
| Age (years)a | 30.9 (5.9) | 31.2 (6.5) | 0.891 |
| Sex (male:female)b | 24:8 | 27:5 | 0.351 |
| Weight (Kg)a | 71.5 (11.2) | 73.2 (11.1) | 0.547 |
| Height (m)a | 174.7 (7.4) | 175.8 (6.2) | 0.501 |
| BMI (kg/m2)a | 23.3 (2.1) | 23.6 (2.4) | 0.631 |
| Physical activity (days/week)a | 3.8 (1) | 4.3 (1.4) | 0.055 |
| Physical activity (hours/day)a | 1.9 (1.5) | 2.1 (1.2) | 0.657 |
| Laterality (Right:Left)b | 24:8 | 23:9 | 0.719 |
| Symptoms duration (months)a | 29.5 (31.5) | 28.8 (32.4) | 0.929 |
| # of previous episodes paina | 3.3 (2.3) | 3.7 (2.6) | 0.543 |
| Time from the start of the last episode (months) a | 2.2 (0.9) | 2.8 (2.9) | 0.277 |
| Thickening of the tendon (Yes: No) b | 32:0 | 32:0 | 1.000 |
| Vascularization (Yes: No) b | 23:9 | 22:10 | 1.000 |
a Statistics: Mean (standard deviation); p = Student t test. b Frequencies, p = Chi square
Score on the VISA-P scale at the initial and final evaluation by treatment Group
| VISA-p Initial Eval.a | VISA-p Final Eval.a |
| ||
|---|---|---|---|---|
| Group 1 (Electro-physiotherapy) | VISA-p < 90 | 52.5(18.8) [43.5-61.6] | 61.9 (13,7) [55.3–68.5] |
|
| VISA-p > 90 | 69.1 (9.1) [62.9-75.2] | 95.2 (2.5) [93.5-96.9] |
| |
| Group 2 (USGET) | VISA-p < 90 | 51.4 (17.9) [36.4-66.3] | 63.3 (14.3) [51.3-75.2] |
|
| VISA-p > 90 | 66.3 (13.1) [60.5-72.1] | 97.1 (1.7) [96.3-97.8] |
| |
| TOTAL | VISA-p < 90 | 52.2 (18.2) [44.9-59.4] | 62.3 (13.6) [56.9-67.7] |
|
| VISA-p > 90 | 67.2 (11.2) [63.0-71.4] | 96.4 (2.1) [95.7-97.2] |
|
a Victorian Institute of Sport Assessment-Patella (VISA-P) values expressed as mean (±SD) and [coefficient interval]. b p = non-parametric Wilcoxon test
Ranked as not healed (VISA-P < 90) and healed (VISA-P ≥ 90) at the final follow-up
Fig. 1Error bar chart for the confidence interval at 95% at the start and end VISA-P scores in each treatment group. Subjects ranked as VISA-P > 90 and VISA-P < 90
Fig. 2Scatter plot between the scores at the start and end VISA-P in each treatment group. It distinguishes subjects with VISA-P > 90 and VISA-P < 90
Correlation analysis for the whole series
| CORRELATIONS | ||||
|---|---|---|---|---|
| VISA-P Last Eval. | ||||
| TOTAL | Group 1 (Electro-physiotherapy) | VISA-P Initial Eval. | (r) | 0,774 |
| (r2) | 0,599 (59,9%) | |||
|
| 0,000 | |||
| Group 2 (USGET) | VISA-P Initial Eval. | (r) | 0,57 | |
| (r2) | 0,325 (32,5%) | |||
|
| 0,001 | |||
| TOTAL | VISA-P Initial Eval. | (r) | 0,676 | |
| (r2) | 0,457 (45,7%) | |||
|
| 0,000 | |||
| VISA-P < 90 Final Eval. | Group 1 (Electro-physiotherapy) | VISA-P Initial Eval. | (r) | 0,88 |
| (r2) | 0,774 (77,4%) | |||
|
| 0,000 | |||
| Group 2 (USGET) | VISA-P Initial Eval. | (r) | 0,818 | |
| (r2) | 0,669 (66,9%) | |||
|
| 0,013 | |||
| TOTAL | VISA-P Initial Eval. | (r) | 0,859 | |
| (r2) | 0,738 (73,8%) | |||
|
| 0,000 | |||
| VISA-P ≥ 90 Final Eval. | Group 1 (Electro-physiotherapy) | VISA-P Initial Eval. | (r) | −0,491 |
| (r2) | 0,241 (24,1%) | |||
|
| 0,125 | |||
| Group 2 (USGET) | VISA-P Initial Eval. | (r) | −0,136 | |
| (r2) | 0,018 (1,8%) | |||
|
| 0,548 | |||
| TOTAL | VISA-P Initial Eval. | (r) | −0,262 | |
| (r2) | 0,069 (6,9%) | |||
|
| 0,140 | |||
Victorian Institute of Sport Assessment-Patella (VISA-P). Pearson Correlation Coefficient (r). Coefficient of Determination (r2) (% of Variance Explained). p = non-parametric Wilcoxon test
Number of sessions and duration of treatment by Group and ranked as not healed (VISA-p < 90) or healed (VISA-p ≥ 90) at the final follow-up
| GROUP 1 (Electro-physiotherapy) | Group 2 (USGET) | |||||
|---|---|---|---|---|---|---|
| Not healed | Healed | TOTAL | Not healed | Healed | TOTAL | |
| NUMBER SESSIONSa | 24(0) [24–24] | 36.3(5.04) [32.9–39.7] | 38.7(3.5) [37.3–39.9] | 4(0) [4–4] | 3.0(0.9) [2.6–3.4] | 3.3(0.9) [2.9–3.6] |
| TREATMENT TIME (Days)a | 56(0) [56–56] | 50.9(7.1) [46.1–55.6] | 54.1(4.8) [52.3–55.9] | 56(0) [56–56] | 42.0(13.6) [35.9–48.0] | 45.7(13.2) [40.8–50.6] |
a Statistics: Mean (standard deviation) [95% confidence interval]. No statistically significant differences were seen when comparing the number of sessions or time of treatment used in the comparison of both groups
Fig. 3Cumulative survival graph in each of the treatment groups, VISA-P > 90 being the event studied